TK1 and breast carcinoma: In that sense, TK1 may not seem initially appealing or particularly sophisticated, in that its simplicity and potential generalisability across different tumour types does not represent the hallmark of a truly “personalised” marker that is unique to the biology of breast cancer or to its clinical management.